The dollar amount is too small to signal a material change in outlook. Monitor next 10-Q for any shift in insider selling patterns or acceleration of share disposals by C-suite officers.
GKOS drugs
GKOS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $224.41entry
- T+1 · 8d ago +6.39%α +4.02% · $238.74
- T+5 · 4d ago +9.50%α +6.90% · $245.72
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Two insiders at Glaukos sold a combined $3.06M in open-market stock within 8 days of the company reporting record Q3 revenue (+58% YoY) and raising FY 2026 guidance. The sales are not under 10b5-1 plans and represent 0.02% of market cap, which is trivial relative to company size.
Key Financial Metrics
Key Facts
- Director Kliman Gilbert H sold 2,500 shares at $253 for $633K on 2026-11-04 (no 10b5-1 plan)
- Chief Development Officer Navratil Tomas sold 10,200 shares at $237.54 for $2.43M on 2026-10-30 (no 10b5-1 plan)
- Total open-market sales of $3.06M represent ~0.02% of Glaukos' $13.8B market cap
- Sales occurred 2-8 days after Glaukos reported Q3 record net sales of $211M (+58% YoY) and raised FY 2026 guidance to $775M-$785M
Financial Impact
Total insider sales of $3.06M, negligible relative to $13.8B market cap
Risk Factors
- Insider sales not under 10b5-1 plans could indicate personal portfolio rebalancing rather than negative outlook
- No C-suite CEO or CFO selling in this cluster reduces signal significance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GKOS-1793925182244 |
Track record
16 reports on GKOS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $242.67 Now $244.88 +0.91% settles Nov 23
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $245.72 Now $244.88 −0.34% settles Nov 20
- Nov 6, 202610d ago 8-K Neutral 3/10 Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Viewing Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
- Oct 30, 202617d ago 144 Neutral 3/10 Entry $237.60 to $224.41 Now $244.88 +3.06% ▼ −5.55% −2.85% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $242.48 to $219.98 Now $244.88 +0.99% ▼ −9.28% −4.55% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 3/10 Entry $184.53 to $184.89 Now $244.88 +32.70% ▲ +0.20% +1.56% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $186.63 to $189.55 Now $244.88 +31.21% ▲ +1.56% +2.01% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers